September 21, 2022
Following the success of the November 2021 focus groups for IgG4-RD patients, the Alliance for Patience Access hosted another focus group to capture additional insights.
September 20, 2022
The U.S. Food and Drug Administration’s standard approval process for new drugs delivers patients the safest, most advanced medications in the world.
August 18, 2022
Hepatitis C is a paradox of American health care. The medical community has never been better equipped to diagnose, cure and prevent this potentially fatal liver disease.
July 29, 2022
The fifth annual Cardiovascular Health Policy Summit, held on June 9, welcomed policy
experts, patient advocates and health care providers to address patients’ pressing
needs and explore policy solutions that will improve the lives of Americans with
July 15, 2022
The Centers for Medicare and Medicaid Services is rethinking a policy that limits millions of Americans’ access to one of the most effective resources for diagnosing and determining the course of treatment for Alzheimer’s disease.
July 13, 2022
Evidence continues to mount that exclusion lists – lists of prescription drugs that payers refuse to cover – have less to do with patients and more to do with profits.
July 7, 2022
A new treatment is expanding options for the 40 million people living with migraine disease.
July 5, 2022
Even as the federal investigation of pharmacy benefit managers begins, patients continue to get cheated by the companies’ practices.
June 30, 2022
More than two in five American adults are obese. Annually, 300,000 people die from the illness and hundreds of thousands more from related conditions.
June 28, 2022
The behind-the-scenes, yet powerful companies who control patients’ access to drugs may soon have to answer for their tactics.